Mark Schoenberg: insider trades

Every open market trade Mark Schoenberg has filed with the SEC, when each filing appeared, and how the buys did against the S&P 500 once the filing was public.

Key Facts

  • Mark Schoenberg is listed as Chief Medical Officer at URGN.
  • Between 2026-06-09 (9 June 2026) and 2026-09-09 (9 September 2026) Mark Schoenberg filed 0 open market buys worth $0 and 5 open market sales worth $3.8M.
  • None of Mark Schoenberg's buys has matured 90 days yet, so there is no return to report.
  • Data as of 2026-09-29 (29 September 2026).
Open market buys 0 $0
Open market sales 5 $3.8M
Avg vs S&P, 90d n/a 0 scored buys
Beat the S&P n/a 90 days after entry

Would copying Mark Schoenberg have paid?

prices as of 2026-09-28

The result. None of Mark Schoenberg's buys has matured 90 days yet, so there is no return to report.

Average return of Mark Schoenberg's open market buys against the S&P 500.
Days after entryScored buysAvg vs S&PBeat S&PEntry monthst statisticReading
30 days 0 n/a n/a n/a n/a too few trades to tell
90 days 0 n/a n/a n/a n/a too few trades to tell
180 days 0 n/a n/a n/a n/a too few trades to tell

A return curve needs at least 10 scored buys. Mark Schoenberg does not have enough yet.

Stocks traded

  1. URGN5 trades, $3.8M

Every open market trade

as of 2026-09-29
5 trades.
Open market trades filed by Mark Schoenberg, newest first.
FiledStockTypeSharesPriceValue90 day vs S&P
9 Sep 2026 URGN sell 871 $42.92 $37.4K n/a
24 Aug 2026 URGN sell 60,677 $47.05 $2.9M n/a
10 Jul 2026 URGN sell 10,000 $40.00 $400K n/a
24 Jun 2026 URGN sell 10,000 $35.01 $350K n/a
9 Jun 2026 URGN sell 5,222 $27.30 $143K n/a

Insider sales are shown but not scored, because they are often planned for tax or diversification reasons.

Frequently asked questions

What has Mark Schoenberg bought and sold?

Between 2026-06-09 (9 June 2026) and 2026-09-09 (9 September 2026) Mark Schoenberg filed 0 open market buys worth $0 and 5 open market sales worth $3.8M.

Did Mark Schoenberg's buys beat the market?

None of Mark Schoenberg's buys has matured 90 days yet, so there is no return to report. Insider sales are not scored because they are often planned for tax or diversification reasons.

Sources: Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.